Immediate Impact

2 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
4 intermediate papers

Works of Donna Lancaster being referenced

Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma
2016
Dosimetry for Fractionated 131 I-mIBG Therapies in Patients with Primary Resistant High-Risk Neuroblastoma: Preliminary Results
2007

Author Peers

Author Last Decade Papers Cites
Donna Lancaster 198 177 77 120 21 461
C Béhar 149 178 72 80 32 413
B. Stollmann 243 223 62 101 21 430
April Sorrell 194 303 98 68 18 475
Susan Russell 92 157 52 92 26 413
Byung-Kiu Park 101 84 85 101 27 478
Glicksman As 157 99 63 62 13 434
Ardine Reedijk 196 96 28 185 23 479
Susan R. Wiersma 174 257 74 48 16 510
Tanya Watt 106 77 44 98 23 458
H. Spaar 264 153 71 139 35 532

All Works

Loading papers...

Rankless by CCL
2026